Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Rapid identification of genomic structural variations with nanopore sequencing enables blood-based cancer monitoring

Jose Espejo Valle-Inclan, Christina Stangl, Anouk C. de Jong, Lisanne F. van Dessel, Markus J. van Roosmalen, Jean C.A. Helmijr, Ivo Renkens, Sam de Blank, Chris J. de Witte, John W.M. Martens, Maurice P.H.M. Jansen, Martijn P. Lolkema, Wigard P. Kloosterman
doi: https://doi.org/10.1101/19011932
Jose Espejo Valle-Inclan
UMC Utrecht, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jespejov@umcutrecht.nl
Christina Stangl
UMC Utrecht, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: c.s.stangl@umcutrecht.nl
Anouk C. de Jong
Erasmus MC, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: a.c.dejong@erasmusmc.nl
Lisanne F. van Dessel
Erasmus MC, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: l.vandessel@erasmusmc.nl
Markus J. van Roosmalen
Princess Maxima Center, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m.j.vanroosmalen-3@prinsesmaximacentrum.nl
Jean C.A. Helmijr
Erasmus MC, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: j.helmijr@erasmusmc.nl
Ivo Renkens
UMC Utrecht, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: i.renkens@umcutrecht.nl
Sam de Blank
UMC Utrecht, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: s.deblank@students.uu.nl
Chris J. de Witte
UMC Utrecht, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: c.j.dewitte-2@umcutrecht.nl
John W.M. Martens
Erasmus MC, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: j.martens@erasmusmc.nl
Maurice P.H.M. Jansen
Erasmus MC, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m.p.h.m.jansen@erasmusmc.nl
Martijn P. Lolkema
Erasmus MC, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m.lolkema@erasmusmc.nl
Wigard P. Kloosterman
UMC Utrecht, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wigardkloosterman@gmail.com
  • Abstract
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Somatic genomic structural variations (SVs) are promising personalized biomarkers for sensitive and specific detection of circulating tumor DNA (ctDNA) in liquid biopsies. However, affordable and fast identification of such SV biomarkers is challenging, which hinders routine use in the clinic. Here, we developed a novel approach - termed SHARC - for rapid discovery of somatic SVs as personalized tumor biomarkers. SHARC combines low coverage cancer genome sketching by using Oxford Nanopore sequencing with random forest classification and a dedicated filtering pipeline to enrich for somatic SVs. Our method leverages the real-time and long-read capabilities of nanopore sequencing to identify somatic SV breakpoints at nucleotide resolution from a tumor tissue biopsy within three days. We applied SHARC to tumor samples of high-grade ovarian and prostate cancer and validated on average ten somatic SVs per sample with PCR mini-amplicons. An accompanying method for SV breakpoint detection from liquid biopsies was devised based on digital PCR, enabling detection of cancer in a quantitative manner. Using this method, we retrospectively monitored treatment response in patients with metastatic prostate cancer. Our work demonstrates that SHARC forms a universal framework for rapid development of personalized biomarker assays for blood-based monitoring of any cancer type.

Competing Interest Statement

J.E.V-I, C.S. and W.P.K. have received financial compensation for travel and accommodation expenses to speak at Oxford Nanopore Technologies-organized meetings. The remaining authors declare no competing financial interests.

Funding Statement

This work has been supported by KWF grants UU 2012-5710 and by funding from the Utrecht University to implement a single-molecule sequencing facility.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Nanopore sequencing data is available in ENA and EGA as follows: COLO829 cell line: ENA accession ERX2765498. HGS-3 organoid line: EGA dataset accession EGAD00001005476 Patient material: EGA study accession EGAS00001003963

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted November 15, 2019.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Rapid identification of genomic structural variations with nanopore sequencing enables blood-based cancer monitoring
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
Share
Rapid identification of genomic structural variations with nanopore sequencing enables blood-based cancer monitoring
Jose Espejo Valle-Inclan, Christina Stangl, Anouk C. de Jong, Lisanne F. van Dessel, Markus J. van Roosmalen, Jean C.A. Helmijr, Ivo Renkens, Sam de Blank, Chris J. de Witte, John W.M. Martens, Maurice P.H.M. Jansen, Martijn P. Lolkema, Wigard P. Kloosterman
medRxiv 19011932; doi: https://doi.org/10.1101/19011932
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Rapid identification of genomic structural variations with nanopore sequencing enables blood-based cancer monitoring
Jose Espejo Valle-Inclan, Christina Stangl, Anouk C. de Jong, Lisanne F. van Dessel, Markus J. van Roosmalen, Jean C.A. Helmijr, Ivo Renkens, Sam de Blank, Chris J. de Witte, John W.M. Martens, Maurice P.H.M. Jansen, Martijn P. Lolkema, Wigard P. Kloosterman
medRxiv 19011932; doi: https://doi.org/10.1101/19011932

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (5)
  • Allergy and Immunology (5)
  • Anesthesia (5)
  • Cardiovascular Medicine (36)
  • Dentistry and Oral Medicine (1)
  • Dermatology (8)
  • Emergency Medicine (3)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (18)
  • Epidemiology (145)
  • Forensic Medicine
  • Gastroenterology (14)
  • Genetic and Genomic Medicine (58)
  • Geriatric Medicine (8)
  • Health Economics (5)
  • Health Informatics (42)
  • Health Policy (13)
  • Health Systems and Quality Improvement (10)
  • Hematology (3)
  • HIV/AIDS (29)
  • Infectious Diseases (except HIV/AIDS) (53)
  • Intensive Care and Critical Care Medicine (5)
  • Medical Education (18)
  • Medical Ethics (3)
  • Nephrology (5)
  • Neurology (62)
  • Nursing (4)
  • Nutrition (12)
  • Obstetrics and Gynecology (6)
  • Occupational and Environmental Health (11)
  • Oncology (36)
  • Ophthalmology (16)
  • Orthopedics (2)
  • Otolaryngology (6)
  • Pain Medicine (6)
  • Palliative Medicine (1)
  • Pathology (8)
  • Pediatrics (16)
  • Pharmacology and Therapeutics (6)
  • Primary Care Research (7)
  • Psychiatry and Clinical Psychology (72)
  • Public and Global Health (59)
  • Radiology and Imaging (22)
  • Rehabilitation Medicine and Physical Therapy (19)
  • Respiratory Medicine (11)
  • Rheumatology (8)
  • Sexual and Reproductive Health (5)
  • Sports Medicine (7)
  • Surgery (7)
  • Toxicology
  • Transplantation (5)
  • Urology (1)